6th iPSC Drug Development Summit 2026

 

The 6th iPSC Drug Development Summit convenes senior biopharma leaders advancing induced pluripotent stem cell therapies from discovery through clinical scale-up.

The meeting delivers deep, technical discussion across preclinical translation, CMC strategy, GMP-ready manufacturing, and regulatory alignment, with data-driven case studies from companies actively progressing programs. Speaker organizations include BlueRock Therapeutics, Aspen Neuroscience, Century Therapeutics, Astellas Pharma, Oryon Cell Therapies, BroadOak Capital, and more.

Designed for decision-makers shaping development strategy, the summit provides practical insight into execution risks, platform choices, and scalability considerations. Structured networking enables peer-level exchange among developers tackling shared scientific and operational challenges across cell therapy.

Continue Reading To Find out more…

More Info

---

---